These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24913170)

  • 21. Analysis of daptomycin efficacy and breakpoint standards in a murine model of Enterococcus faecalis and Enterococcus faecium renal infection.
    Alder J; Li T; Yu D; Morton L; Silverman J; Zhang XX; Critchley I; Thorne G
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3561-6. PubMed ID: 14576118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular epidemiology of enterococcal bacteremia in Australia.
    Coombs GW; Pearson JC; Daley DA; Le T; Robinson OJ; Gottlieb T; Howden BP; Johnson PD; Bennett CM; Stinear TP; Turnidge JD;
    J Clin Microbiol; 2014 Mar; 52(3):897-905. PubMed ID: 24391201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.
    Lellek H; Franke GC; Ruckert C; Wolters M; Wolschke C; Christner M; Büttner H; Alawi M; Kröger N; Rohde H
    Int J Med Microbiol; 2015 Dec; 305(8):902-9. PubMed ID: 26454536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characteristics of vancomycin-resistant Enterococcus faecium from a tertiary care hospital in Chengdu, China: molecular characteristics of VRE in China.
    Kang M; Xie Y; He C; Chen ZX; Guo L; Yang Q; Liu JY; Du Y; Ou QS; Wang LL
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):933-9. PubMed ID: 24463723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of resistance to daptomycin in Enterococcus faecium.
    Montero CI; Stock F; Murray PR
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1167-70. PubMed ID: 18180351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutant prevention concentrations of daptomycin for Enterococcus faecium clinical isolates.
    Sinel C; Jaussaud C; Auzou M; Giard JC; Cattoir V
    Int J Antimicrob Agents; 2016 Oct; 48(4):449-52. PubMed ID: 27546218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Institution-wide and Within-Patient Evolution of Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium Bloodstream Infections.
    Woods RJ; Patel TS; Nagel JL; Newton DW; Read AF
    Infect Control Hosp Epidemiol; 2018 Feb; 39(2):226-228. PubMed ID: 29331166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo daptomycin nonsusceptibility in a clinical isolate.
    Lesho EP; Wortmann GW; Craft D; Moran KA
    J Clin Microbiol; 2006 Feb; 44(2):673. PubMed ID: 16455945
    [No Abstract]   [Full Text] [Related]  

  • 29. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.
    Kelesidis T; Humphries R; Uslan DZ; Pegues DA
    Clin Infect Dis; 2011 Jan; 52(2):228-34. PubMed ID: 21288849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an
    Belley A; Arhin FF; Moeck G
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance mechanisms and clinical characteristics of linezolid-resistant Enterococcus faecium isolates: A single-centre study in South Korea.
    Cho SY; Kim HM; Chung DR; Kim SH; Huh HJ; Kang CI; Peck KR; Lee NY; Song JH
    J Glob Antimicrob Resist; 2018 Mar; 12():44-47. PubMed ID: 28941790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic features and molecular epidemiology of Enterococcus faecium isolated in two university hospitals in Brazil.
    da Silva LP; Pitondo-Silva A; Martinez R; da Costa Darini AL
    Diagn Microbiol Infect Dis; 2012 Nov; 74(3):267-71. PubMed ID: 22959818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada.
    Patel SN; Memari N; Shahinas D; Toye B; Jamieson FB; Farrell DJ
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):350-3. PubMed ID: 24095643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium.
    Humphries RM; Kelesidis T; Tewhey R; Rose WE; Schork N; Nizet V; Sakoulas G
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6051-3. PubMed ID: 22948885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.
    Lewis JS; Owens A; Cadena J; Sabol K; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1664-5. PubMed ID: 15793168
    [No Abstract]   [Full Text] [Related]  

  • 36. Whole Genome Sequence Analysis of the First Vancomycin-Resistant
    Ahmed MO; Elramalli AK; Baptiste KE; Daw MA; Zorgani A; Brouwer E; Willems RJL; Top J
    Microb Drug Resist; 2020 Nov; 26(11):1390-1398. PubMed ID: 32181678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
    Carter GP; Harjani JR; Li L; Pitcher NP; Nong Y; Riley TV; Williamson DA; Stinear TP; Baell JB; Howden BP
    J Antimicrob Chemother; 2018 Jun; 73(6):1562-1569. PubMed ID: 29518208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Phenotypic and Genotypic Diversity of
    Mayoral-Terán C; Flores-Moreno K; Cevallos MA; Volkow-Fernández P; Castillo-Ramírez S; Graña-Miraglia L; López-Vidal Y
    Microb Drug Resist; 2020 Mar; 26(3):227-237. PubMed ID: 31545121
    [No Abstract]   [Full Text] [Related]  

  • 39. Nationwide Surveillance of Novel Oxazolidinone Resistance Gene optrA in Enterococcus Isolates in China from 2004 to 2014.
    Cui L; Wang Y; Lv Y; Wang S; Song Y; Li Y; Liu J; Xue F; Yang W; Zhang J
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7490-7493. PubMed ID: 27645239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A High Daptomycin Dose Is Associated with Better Bacterial Clearance in Infections Caused by Vancomycin-Resistant Enterococcus faecium Regardless of Daptomycin Minimum Inhibitory Concentration in a Rat Infective Endocarditis Model.
    Wang JT; Yang CJ; Yang JL; Lin SW; Chuang YC; Sheng WH; Chen YC; Chang SC
    Microbiol Spectr; 2022 Oct; 10(5):e0255122. PubMed ID: 36190402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.